Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

ISIS-14803 begins phase I/II evaluation as HCV treatment

March 2, 2000

Hepatitis C vaccine candidate identified by Epimmune

March 2, 2000

Searle identifies novel series of LTA4 hydrolase inhibitors, some with good oral activity

Feb. 29, 2000

Hepatitis C product candidate enters phase I testing in U.K.

Feb. 29, 2000

Millennium commences phase II clinical trial of LDP-02 for treatment of Crohn's disease

Feb. 28, 2000

Altus receives funding for GI lipase enzyme therapy

Feb. 24, 2000

Telomerase gene therapy may offer potential liver cirrhosis therapy

Feb. 24, 2000

CPMP issues positive opinion regarding PEG-Intron MAA

Feb. 23, 2000

BioMedicines files IND for interferon omega

Feb. 22, 2000

Agents for HCV under study at Ajinomoto

Feb. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...